Model
Edge
Seres Therapeutics
0001767321
Filing Type
4
Filing Date
2/17/2026
Updated
2/18/26, 2:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership